Summary
A previously suggested model for the correlation between residual activity of a lysosomal enzyme and the turnover rate of its substrate(s) has been extended to a discussion of substrate accumulation rates in individual cells and whole organs. With these considerations, much of the observed variability in age of onset and clinical phenotype, as well as the phenomenon of pseudodeficiency, can be understood as the consequences of small differences in the residual activity of the affected enzyme. In order to experimentally verify the basic assumptions on which this model rests, studies were performed in cell culture. The radiolabeled substrates ganglioside GM2 and sulfatide were added to cultures of skin fibroblasts with different activities of β-hexosaminidase A or arylsulfatase A, respectively, and their uptake and turnover measured. In both series of experiments, the correlation between residual enzyme activity and the turnover rate of the substrate was essentially as predicted: degradation increased steeply with residual activity, to reach the control level at a residual activity of approximately 10–15% of normal. All cells with an activity above this critical threshold had a normal turnover. Comparison of the results of these feeding studies with the clinical status of the donor of each cell line basically confirmed our notions but also revealed the limitations of the cell culture approach.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Banerjee A, Burg J, Conzelmann E, Carroll M, Sandhoff K (1984) Enzyme-linked immunosorbent assay for the ganglioside GM2-activator protein. Screening of normal human tissues and body fluids, of tissues of GM2 gangliosidosis, and for its subcellular localization. Hoppe-Seyler's Z Physiol Chem 365:347–356
Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–917
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Conzelmann E, Sandhoff K (1979) Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A. Hoppe-Seyler's Z Physiol Chem 360:1837–1849
Conzelmann E, Sandhoff K (1983/84) Partial enzyme deficiencies: residual activities and the development of neurologic disorders. Dev Neurosci 6:58–71
Conzelmann E, Sandhoff K (1987a) Activator proteins for lysosomal glycolipid hydrolysis. In: Glick D (ed) Methods of biochemical analysis, vol 32. Wiley, New York, pp 1–23
Conzelmann E, Sandhoff K (1987b) Activator proteins for lysosomal glycolipid hydrolysis. Methods Enzymol 138:792–815
Conzelmann E, Kytzia H-J, Navon R, Sandhoff K (1983) Ganglioside GM2 N-acetyl-β-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase levels. Am J Hum Genet 35:900–913
Conzelmann E, Nehrkorn H, Kytzia H-J, Sandhoff K, Macek M, Lehovsky M, Elleder M, Jirasek A, Kobilkova J (1985) Prénatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (Variant B1; pseudo AB variant) Pediatr Res 19:1220–1224
Federico A, Palmeri S, Mangano L, Mondelli M, Rossi A, Guazzi GC (1987) Clinical and neurophysiological changes in carriers from a family with type 0 chronic GM2 gangliosidosis with ALS phenotype. In: Salvayre R, Douste-Blazy L, Gatt S (eds) Lipid storage disorders — biological and medical aspects. (NATO ASI Series, vol A 150) Plenum Press, New York, pp 253–258
Harzer K, Kustermann-Kuhn B (1987) Brain galactolipid content in a case with pseudo arylsulfatase A deficiency and coincidental diffuse disseminated sclerosis and in cases with metachromatic, adreno-and other leukodystrophies. J Neurochem 48:62–66
Hasilik A, von Figura K, Conzelmann E, Nehrkorn H, Sandhoff K (1982) Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D-precursors in vitro and activity of β-hexosaminidase A precursor towards ganglioside GM2. Eur J Biochem 125:317–321
Heukels-Dully MJ, Niermeijer MF (1976) Variation in lysosomal enzyme activity during growth in culture of human fibroblasts and amniotic fluid cells. Exp Cell Res 97:304–312
Hoffman LM, Amsterdam D, Brooks SE, Schneck L (1977) Glycosphingolipids in fetal Tay-Sachs disease brain and lung cultures. J Neurochem 29:551–559
Hohenschutz C, Friedl W, Schlör K-H, Waheed A, Conzelmann E, Sandhoff K, Propping P (1988) A probable MLD/PD compound at the arylsulfatase A locus with neurological and psychiatric symptomatology. Am J Med Genet 31:169–175
Hohenschutz C, Eich P, Friedl W, Waheed A, Conzelmann E, Propping P (1989) Pseudodeficiency of arylsulfatase A: a common genetic polymorphism with possible disease implications. Hum Genet 82:45–48
Hreidarsson SJ, Thomas GH, Kihara H, Fluharty AL, Kolodny EH, Moser HW, Reynolds LW (1983) Impaired cerebroside sulfate hydrolysis in fibroblasts of sibs with “pseudo” arylsulfatase A deficiency without metachromatic leukodystrophy. Pediatr Res 17:701–704
Kappler J, Leinekugel P, Conzelmann E, Kleijer WJ, Kohlschütter A, Tønnesen T, Rochel M, Freycon F, Propping P (1991a) Genotype-phenotype relationship in various degrees of arylsulfatase A deficiency. Hum Genet 86:463–470
Kappler J, Watts RWE, Conzelmann E, Gibbs DA, Propping P, Gieselmann V (1991b) Low arylsulfatase A acitivity and choreoathetotic syndrome in three siblings: Differentiation of pseudodeficiency from metachromatic leukodystrophy. Eur J Pediatr 150:287–290
Kihara H, Ho C-K, Fluharty AL, Tsay KK, Hartlage PL (1980) Prenatal diagnosis of metachromatic leukodystrophy in a family with pseudo arylsulfatase A deficiency by the cerebroside sulfate loading test. Pediatr Res 14:224–227
Kolodny EH (1989) Metachromatic leukodystrophy and multiple sulfatase deficiency: sulfatide lipidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The methabolic basis of inherited disease, 6th end. McGraw-Hill, New York, pp 1721–1750
Kresse H, Fuchs W, Glössl J, Holtfrerich D, Gilberg W (1981) Liberation of N-acetylglucosamine-6-sulfate by human β-N-acetyl-hexosaminidase A. J Biol Chem 256:12926–12932
Lapidot Y, Rappaport S, Woleman Y (1967) Use of esters of N-hydroxysuccinimide in the synthesis of N-acylamino acids. J Lipid Res 8:142–145
Lee-Vaupel M, Conzelmann E (1987a) A simple chromogenic assay for arylsulfatase A. Clin Chim Acta 164:171–180
Lee-Vaupel M, Conzelmann E (1987b) Assay for cerebroside sulfate (sulfatide) sulfatase in cultured skin fibroblasts with the natural activator protein. Clin Chim Acta 168:55–68
Miller AL, Kress BC, Stein R, Kinnon C, Schneider JA, Harms E (1981) Properties of N-acetyl-β-D-hexosaminidase from isolated normal and I-cell lysosomes. J Biol Chem 256:9352–9362
Molzer B, Sundt-Heller R, Kainz-Korschinsky M, Bernheimer H (1989) Increased sulphatide excretion in metachromatic leukoystrophy heterozygotes. J Clin Chem Clin Biochem 27:755
Navon R, Argov Z, Frisch A (1986) Hexosaminidase deficiency in adults. Am J Med Genet 24:179–196
Paschke E, Kresse H (1982) Morquio disease, type B: activation of GM1 β-galactosidase by GM1 activator protein. Biochem Biophys Res Commun 109:568–575
Plant JWE (1963) Inosine diphosphatase (nucleoside diphosphatase) from mammalian liver. Methods Enzymol 6:231–236
Polten A, Fluharty AL, Fluharty CB, Kappler J, Von Figura K, Gieselmann V (1991) Molecular basis of different forms of metachromatic leukodystrophy. N Engl J Med 324:18–22
Porter MT, Fluharty AL, Trammell J, Kihara H (1971) A correlation of intracellular cerebroside sulfatase activity in fibroblasts with latency in metachromatic leukodystrophy. Biochem Biophys Res Commun 44:660–666
Raghavan SS, Krusell A, Krusell J, Lyerla TA, Kolodny EH (1985) GM2-Ganglioside metabolism in hexosaminidase A deficiency: determination in situ using labelled GM2 added to fibroblast cultures. Am J Hum Genet 37:1071–1082
Rapin I, Suzuki K, Suzuki K, Valsamis MP (1976) Adult (Chronic) GM2 gangliosidosis: atypical spinocerebellar degeneration in a Jewish sibship. Arch Neurol 33:120–130
Sandhoff K, Conzelmann E, Neufeld EF, Kaback MM, Suzuki K (1989) The GM2 Gangliosidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. 6th edn. McGraw-Hill, New York, pp 1807–1839
Schwarzmann G (1978) A simple and novel method for tritium labeling of gangliosides and other sphingolipids. Biochim Biophys Acta 529:106–114
Schwarzmann G, Sandhoff K (1987) Lysogangliosides: synthesis and use in preparing labeled gangliosides. Methods Enzymol 138:319–341
Sonderfeld S, Conzelmann E, Schwarzmann G, Burg J, Hinrichs U, Sandhoff K (1985) Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects. Eur J Biochem 149:247–255
Sonnino S, Kirschner G, Ghidoni R, Acquotti D, Tettamanti G (1985) Preparation of GM1 ganglioside molecular species having homogeneous fatty acid and long chain base moieties. J Lipid Res 26:248–257
Suzuki Y, Suzuki K (1972) Specific radioactive labeling of terminal N-acetylgalactosamine of glycosphingolipids by galactose oxidase-sodium borohydride method. J Lipid Res 13:687–690
Suzuki K, Suzuki Y (1989) Galactosylceramide lipidosis: globoid cell leukodystrophy (Krabbe disease) In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease 6th edn. McGraw-Hill, New York, pp 1699–1720
Svennerholm L (1972) Gangliosides, isolation. Methods Carbohydr Chem 6:464–474
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leinekugel, P., Michel, S., Conzelmann, E. et al. Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet 88, 513–523 (1992). https://doi.org/10.1007/BF00219337
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00219337